litgenprostucel-l
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2008 (NCT00577356)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2108618 ↗
Also known as
- cg8711
- cg-8711
- litgenprostucel-l
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00577356 | Phase 2 | Feb 1, 2008 | Cell Genesys, Sanofi, Virginia Mason Medical Center |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cell Genesys | For profit | 1 | 0 | 1 | 2008 |
| Sanofi | For profit | 1 | 0 | 1 | 2008 |
| Virginia Mason Medical Center | Academic/Hospital | 1 | 1 | 1 | 2008 |
3 organizations
Page 1 / 1